An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option

G. Manzotti, F. Torricelli, D. Benedetta, F. Lococo, V. Sancisi, G. Rossi, S. Piana, A. Ciarrocchi

Research output: Contribution to journalArticlepeer-review

Cite this